Private equity firm Deerfield earmarks $600M for healthcare investments
Private equity investors at Deerfield Management released details on its latest Healthcare Innovations Fund program, reserving more than $600 million for “promising therapeutics” and “elevating emerging technologies” that support care delivery, including artificial intelligence.
“There has never been a better time to invest in new and evolving technologies and products across the life science, medical technology, and healthcare service landscape,” James Flynn, Managing Partner at Deerfield, said in a statement. “Advancing knowledge, data, and software capabilities are transforming what is possible to achieve in improving health outcomes."
In its announcement, the firm said a portion of profits from any investment it makes will be donated to its not-for-profit Deerfield Foundation, an organization it founded to advance children’s health nationwide.
“Deerfield recognizes that advancing healthcare requires more than a for-profit investment model can provide,” the company stated, adding that its charitable contributions have been a long-standing practice.”
Housed at a twelve-story campus located in New York City dubbed “Cure" that serves as Deerfield's headquarters, the company said all of its partners benefit from its internal staff and infrastructure, which includes experts from across the healthcare continuum, as well as “state-of-the-art research laboratories and convening spaces.”
It added that 29 research institutions back its work and help fuel innovations in support of the services and technologies of its vested interests.
At its campus, the group stated that it employs 180 people, whose expertise can be leveraged by "corporate and strategic partners.”
Founded in 2005, Deerfield launched its Healthcare Innovations Fund in 2015, supporting advancements across the healthcare spectrum—from drug and medical device development to technologies that enhance hospital workflows and infrastructure, including AI.
The fund is now in its third iteration, with new investments in healthcare companies expected to begin immediately.
Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.